BlackRock’s Tyra Biosciences TYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.1M Buy
1,893,328
+197,411
+12% +$1.89M ﹤0.01% 3044
2025
Q1
$15.8M Sell
1,695,917
-22,587
-1% -$210K ﹤0.01% 3036
2024
Q4
$23.9M Buy
1,718,504
+202,332
+13% +$2.81M ﹤0.01% 2887
2024
Q3
$35.6M Buy
1,516,172
+97,317
+7% +$2.29M ﹤0.01% 2636
2024
Q2
$22.7M Buy
1,418,855
+374,630
+36% +$5.99M ﹤0.01% 2864
2024
Q1
$17.1M Buy
1,044,225
+79,191
+8% +$1.3M ﹤0.01% 3020
2023
Q4
$13.4M Buy
965,034
+68,582
+8% +$950K ﹤0.01% 3180
2023
Q3
$12.3M Buy
896,452
+5,620
+0.6% +$77.4K ﹤0.01% 3158
2023
Q2
$15.2M Buy
890,832
+223,947
+34% +$3.81M ﹤0.01% 3131
2023
Q1
$10.7M Buy
666,885
+11,794
+2% +$190K ﹤0.01% 3210
2022
Q4
$4.98M Buy
655,091
+32,993
+5% +$251K ﹤0.01% 3659
2022
Q3
$5.47M Sell
622,098
-8,757
-1% -$77K ﹤0.01% 3641
2022
Q2
$4.51M Buy
630,855
+47,619
+8% +$340K ﹤0.01% 3787
2022
Q1
$6.24M Sell
583,236
-5,330
-0.9% -$57K ﹤0.01% 3757
2021
Q4
$8.28M Buy
+588,566
New +$8.28M ﹤0.01% 3716